EUVIMEDEUVIMED entdecken
Open Access

Next Generation 3D Printed Multipurpose Intravaginal Ring For Sustained Co-Delivery of Antiretroviral Drugs and A Contraceptive Hormone

Denali K Dahl, Rima Janusziewicz, Roopali Shrivastava, Panita Maturavongsadit, Evan Chan, Stephanie A Montgomery, S Rahima Benhabbour

Pharmaceutical Research · 2025

DOI: 10.1007/s11095-025-03969-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Research, 2025. Verfasst von Denali K Dahl und 6 weiteren Autor:innen. Beteiligte Einrichtung: Lampe Joint Department of Biomedical Engineering, North Carolina State University and The University of North Carolina at Chapel Hill, Chapel Hill, N…. Hauptthemen laut MEDLINE: Printing, Three-Dimensional, Contraceptive Devices, Female, Levonorgestrel, Anti-HIV Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Globally, a significant overlap exists between females affected by HIV and HSV-2 infections, and who have an unmet need for contraception. Intravaginal rings (IVRs) have become widely accepted by women worldwide for contraception and hormone replacement therapy and provide a promising platform as a multipurpose prevention technology (MPT). METHODS: Using state-of-the-art 3D printing process known as continuous liquid interface production (CLIP™), IVRs with an internal honeycomb (HC 2.53 mm) geometry were fabricated with a silicone-urethane resin. IVRs were loaded with a triple-drug combination of an anti-HIV drug (Dapivirine, DPV, 30 mg), an anti-herpes drug (Pritelivir, PTV, 20 mg) and a contraceptive hormone (Levonorgestrel, LNG, 2.0 mg) using a solvent swelling method in acetone. RESULTS: IVRs elicited zero-order release kinetics following an initial burst for all three APIs when formulated individually or in combination. Release rates were above benchmark therapeutic targets for DPV and LNG (200 µg/day DPV, 20 µg/day LNG). A series of accelerated stability studies demonstrated the physical integrity of IVRs after 6 months of storage at 40ºC/75%RH. DPV remained stable over 6 months, whereas PTV and LNG exhibited significant decrease in concentration after 3 months of storage with presence of degradation products detected by HPLC. Mouse size placebo rings (3 mm OD) elicited 100% cell viability in relevant cell lines and were well tolerated in vivo in mice. CONCLUSIONS: Collectively, these results demonstrate that this first-in-line 3D printed MPT IVR has potential to expand preventative choices for young women and girls against HIV, HSV, and unplanned pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Printing, Three-DimensionalContraceptive Devices, FemaleLevonorgestrelAnti-HIV AgentsFemaleAnimalsHumansMiceAdministration, IntravaginalDrug LiberationDelayed-Action PreparationsHIV InfectionsPyrimidinesDrug Delivery SystemsDrug Combinations

Stichwörter der Autor:innen

3D printingContraceptionControlled drug deliveryHIVHSV-2Intravaginal ring

Substanzen

Delayed-Action PreparationsLevonorgestrelAnti-HIV AgentsDapivirinePyrimidinesDrug Combinations

Autor:innen und Institutionen

  • Lampe Joint Department of Biomedical Engineering, North Carolina State University and The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • AnelleO, Inc., 250 Bell Tower Rd, Chapel Hill, NC, 275141, USA.
  • Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, UNC School of Medicine, Chapel Hill, NC, USA.
  • Lampe Joint Department of Biomedical Engineering, North Carolina State University and The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. benhabs@email.unc.edu.
  • Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. benhabs@email.unc.edu.

Förderung

  • NIAID NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Dahl, D. K., Janusziewicz, R., Shrivastava, R., Maturavongsadit, P., Chan, E., Montgomery, S. A., & Benhabbour, S. R. (2025). Next Generation 3D Printed Multipurpose Intravaginal Ring For Sustained Co-Delivery of Antiretroviral Drugs and A Contraceptive Hormone. Pharmaceutical Research. https://doi.org/10.1007/s11095-025-03969-2

Vancouver

Dahl DK, Janusziewicz R, Shrivastava R, Maturavongsadit P, Chan E, Montgomery SA, et al. Next Generation 3D Printed Multipurpose Intravaginal Ring For Sustained Co-Delivery of Antiretroviral Drugs and A Contraceptive Hormone. Pharmaceutical Research. 2025. doi:10.1007/s11095-025-03969-2

BibTeX
@article{Dahl2025,
  author = {Dahl, Denali K and Janusziewicz, Rima and Shrivastava, Roopali and Maturavongsadit, Panita and Chan, Evan and Montgomery, Stephanie A and Benhabbour, S Rahima},
  title = {Next Generation 3D Printed Multipurpose Intravaginal Ring For Sustained Co-Delivery of Antiretroviral Drugs and A Contraceptive Hormone},
  journal = {Pharmaceutical Research},
  year = {2025},
  doi = {10.1007/s11095-025-03969-2}
}
Kostenlos starten →